Bespoke Extracts, Inc. (BSPK) financial statements (2021 and earlier)

Company profile

Business Address 323 SUNNY ISLES BOULEVARD
SUNNY ISLES, FL 33160
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2581271080870
Cash and cash equivalents2581271080870
Receivables4462  
Inventory, net of allowances, customer advances and progress billings3811362  
Inventory3811362  
Prepaid expense02183120 
Other undisclosed current assets (11)    
Total current assets:300133381751070
Noncurrent Assets
Property, plant and equipment3     
Intangible assets, net (including goodwill)     1
Intangible assets, net (excluding goodwill)     1
Regulated entity, other noncurrent assets  2,056   
Other undisclosed noncurrent assets3334(2,014)4549 
Total noncurrent assets:36344245491
TOTAL ASSETS:335166792201562
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:100601111053769
Other undisclosed accounts payable and accrued liabilities100601111053769
Debt500500 461  
Due to related parties101120004546
Other undisclosed current liabilities    153 
Total current liabilities:701680111566235116
Noncurrent Liabilities
Long-term debt and lease obligation   81193 
Long-term debt, excluding current maturities   81193 
Total noncurrent liabilities:   81193 
Total liabilities:701680111647428116
Stockholders' equity
Stockholders' equity attributable to parent, including:(366)(514)(32)(428)(272)(114)
Common stock229194784327 
Additional paid in capital18,30817,99313,95016,2468,8082,311
Accumulated deficit(18,979)(18,777)(14,136)(16,717)(9,107)(2,428)
Other undisclosed stockholders' equity attributable to parent767676  3
Total stockholders' equity:(366)(514)(32)(428)(272)(114)
TOTAL LIABILITIES AND EQUITY:335166792201562

Income statement (P&L) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Revenues  6216  
Cost of revenue
(Cost of Goods and Services Sold)
(4)(4)(71)(23)  
Other undisclosed gross profit148    
Gross profit:95(9)(7)  
Operating expenses(3,828)(4,020)3,024(7,184)(6,616)(365)
Operating income (loss):(3,819)(4,016)3,014(7,191)(6,616)(365)
Nonoperating expense(607)(625)(433)(419)(63) 
Interest and debt expense(332)(90)(357)(419)(28)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(4,758)(4,730)2,223(8,029)(6,707)(365)
Other undisclosed income from continuing operations before income taxes3329035741928 
Net income (loss) available to common stockholders, diluted:(4,427)(4,641)2,581(7,610)(6,679)(365)

Comprehensive Income ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Net income (loss):(4,427)(4,641)2,581(7,610)(6,679)(365)
Comprehensive income (loss), net of tax, attributable to parent:(4,427)(4,641)2,581(7,610)(6,679)(365)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: